- Home
- AGRI vs QLGN Comparison
AGRI vs QLGN Comparison
Compare AGRI & QLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGRI
- QLGN
- Stock Information
- Founded
- AGRI 2017
- QLGN 1996
- Country
- AGRI Canada
- QLGN United States
- Employees
- AGRI N/A
- QLGN N/A
- Industry
- AGRI
- QLGN Biotechnology: Pharmaceutical Preparations
- Sector
- AGRI
- QLGN Health Care
- Exchange
- AGRI Nasdaq
- QLGN Nasdaq
- Market Cap
- AGRI 3.9M
- QLGN 3.2M
- IPO Year
- AGRI 2021
- QLGN N/A
- Fundamental
- Price
- AGRI $2.59
- QLGN $4.07
- Analyst Decision
- AGRI
- QLGN
- Analyst Count
- AGRI 0
- QLGN 0
- Target Price
- AGRI N/A
- QLGN N/A
- AVG Volume (30 Days)
- AGRI 163.2K
- QLGN 20.7K
- Earning Date
- AGRI 11-19-2024
- QLGN 11-14-2024
- Dividend Yield
- AGRI N/A
- QLGN N/A
- EPS Growth
- AGRI N/A
- QLGN N/A
- EPS
- AGRI N/A
- QLGN N/A
- Revenue
- AGRI $57,596.00
- QLGN N/A
- Revenue This Year
- AGRI $280,570.72
- QLGN N/A
- Revenue Next Year
- AGRI $696.48
- QLGN N/A
- P/E Ratio
- AGRI N/A
- QLGN N/A
- Revenue Growth
- AGRI N/A
- QLGN N/A
- 52 Week Low
- AGRI $2.03
- QLGN $3.34
- 52 Week High
- AGRI $70.60
- QLGN $29.45
- Technical
- Relative Strength Index (RSI)
- AGRI 46.10
- QLGN 45.00
- Support Level
- AGRI $2.24
- QLGN $3.95
- Resistance Level
- AGRI $2.74
- QLGN $4.21
- Average True Range (ATR)
- AGRI 0.21
- QLGN 0.27
- MACD
- AGRI 0.08
- QLGN 0.00
- Stochastic Oscillator
- AGRI 62.57
- QLGN 22.08
About AGRI AgriFORCE Growing Systems Ltd.
AgriFORCE Growing Systems Ltd is an Ag-Tech company with a primary focus on developing and utilizing its intellectual property assets for improvements dedicated to the agricultural industry. The company believes that this goal is best achieved by using its proprietary IP for solutions in the agricultural industry as well as seeking the development of new IP to both enhance the technology which it has already retained in-house as well as development of new technologies which can increase its footprint in the Ag-Tech space. Its AgriFORCE Brands division is focused on the development and commercialization of plant-based ingredients and products that deliver more nutritious food. It will market and commercialize ingredient supplies, like its Awakened Flour and Awakened Grains.
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.